Related Experiment Video
Updated: Oct 13, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular
Nuobei Zhang1, Hao Shen2, Shenan Huang3
1Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University, Nanchang. znbicx@163.com.
Abstract:
The long non-coding FGD5-AS1 (LncFGD5-AS1) has been reported to be a novel carcinogenic gene and participant in regulating tumor progression by sponging microRNAs (miRNAs). However, the pattern of expression and the biological role of FGD5-AS1 in hepatocellular carcinoma (HCC) remains largely unknown. The expression level of FGD5-AS1 in tumor tissues and cell lines was measured by RT-qPCR. CCK-8, EdU, flow cytometry, wound healing, and transwell chamber assays were performed to investigate the role of FGD5-AS1 in cell proliferation, apoptosis, migration, and invasion in HCC. Dual luciferase reporter, and RNA pull-down assays were performed to identify the regulatory interactions among FGD5-AS1, miR-873-5p and GTP-binding protein 4 (GTPBP4). We found that the expression of FGD5-AS1 was upregulated in HCC tissues and cell lines. Moreover, the knockdown of FGD5-AS1 suppressed cell proliferation, migration and invasion, and induced apoptosis in HCC cells. Further studies demonstrated that FGD5-AS1 could function as a competitive RNA by sponging miR-873-5p in HCC cells. Moreover, GTPBP4 was identified as direct downstream target of miR-873-5p in HCC cells and FGD5-AS1mediated the effects of GTPBP4 by competitively binding with miR-873-5p. Taken together, this study demonstrated the regulatory role of FGD5-AS1 in the progression of HCC and identified the miR-873-5p/GTPBP4 axis as the direct downstream pathway. It represents a promising novel therapeutic strategy for HCC patients.
Insights
Long non-coding FGD5-AS1 (LncFGD5-AS1) promotes hepatocellular carcinoma (HCC) progression by sponging miR-873-5p, affecting GTP-binding protein 4 (GTPBP4). This reveals a potential therapeutic target for HCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
- The specific function of FGD5-AS1 in hepatocellular carcinoma (HCC) remains largely uncharacterized.
- LncRNAs can regulate tumor progression by interacting with microRNAs (miRNAs).
Purpose of the Study:
- To investigate the expression pattern and biological role of FGD5-AS1 in HCC.
- To elucidate the molecular mechanism underlying FGD5-AS1's function in HCC progression.
- To identify potential therapeutic targets for HCC based on FGD5-AS1 regulation.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) for expression analysis.
- Cellular assays including CCK-8, EdU, flow cytometry, wound healing, and Transwell assays to assess proliferation, apoptosis, migration, and invasion.
- Dual-luciferase reporter and RNA pull-down assays to determine molecular interactions.
Main Results:
- FGD5-AS1 expression was significantly upregulated in HCC tissues and cell lines.
- Knockdown of FGD5-AS1 inhibited HCC cell proliferation, migration, and invasion, while inducing apoptosis.
- FGD5-AS1 acts as a competing endogenous RNA by sponging miR-873-5p, and regulates GTP-binding protein 4 (GTPBP4) expression via the miR-873-5p/GTPBP4 axis.
Conclusions:
- FGD5-AS1 plays a crucial oncogenic role in HCC progression.
- The miR-873-5p/GTPBP4 axis is identified as a direct downstream pathway regulated by FGD5-AS1.
- Targeting the FGD5-AS1/miR-873-5p/GTPBP4 pathway offers a promising therapeutic strategy for HCC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MicroRNAs
Abnormal Proliferation
TGF - β Signaling Pathway
